| Literature DB >> 28536097 |
Jason E Fish1,2,3, Manuel Cantu Gutierrez4,5,6, Lan T Dang7,2,3, Nadiya Khyzha7,2,3, Zhiqi Chen7,2,3, Shawn Veitch7,2,3, Henry S Cheng7,2,3, Melvin Khor7,2,3, Lina Antounians8,9, Makon-Sébastien Njock7,2,3, Emilie Boudreau7,2,3, Alexander M Herman4,5, Alexander M Rhyner4,5, Oscar E Ruiz10, George T Eisenhoffer6,10,11, Alejandra Medina-Rivera8,12, Michael D Wilson3,8,9, Joshua D Wythe13,5,6.
Abstract
The transcriptional pathways activated downstream of vascular endothelial growth factor (VEGF) signaling during angiogenesis remain incompletely characterized. By assessing the signals responsible for induction of the Notch ligand delta-like 4 (DLL4) in endothelial cells, we find that activation of the MAPK/ERK pathway mirrors the rapid and dynamic induction of DLL4 transcription and that this pathway is required for DLL4 expression. Furthermore, VEGF/ERK signaling induces phosphorylation and activation of the ETS transcription factor ERG, a prerequisite for DLL4 induction. Transcription of DLL4 coincides with dynamic ERG-dependent recruitment of the transcriptional co-activator p300. Genome-wide gene expression profiling identified a network of VEGF-responsive and ERG-dependent genes, and ERG chromatin immunoprecipitation (ChIP)-seq revealed the presence of conserved ERG-bound putative enhancer elements near these target genes. Functional experiments performed in vitro and in vivo confirm that this network of genes requires ERK, ERG and p300 activity. Finally, genome-editing and transgenic approaches demonstrate that a highly conserved ERG-bound enhancer located upstream of HLX (which encodes a transcription factor implicated in sprouting angiogenesis) is required for its VEGF-mediated induction. Collectively, these findings elucidate a novel transcriptional pathway contributing to VEGF-dependent angiogenesis.Entities:
Keywords: Angiogenesis; ETS factor; Endothelial cell; Enhancer; Genome editing; Human; Mouse; Transcription; Zebrafish
Mesh:
Substances:
Year: 2017 PMID: 28536097 PMCID: PMC5536864 DOI: 10.1242/dev.146050
Source DB: PubMed Journal: Development ISSN: 0950-1991 Impact factor: 6.868